CROI 2020 Review: Dual ART & HIV Cure
This talk by Brian Wood addresses the following topics: Dual ART: Dolutegravir/lamivudine initial ART: updated 96-week results Islatravir + doravirine metabolic outcomes at 48 weeks HIV Cure: Sustained HIV remission in the London Patient

▶︎
HHS Interim Guidance for COVID-19 and Persons with HIV

▶︎
Introduction to Suture

▶︎
Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines

▶︎
IAS-USA HIV Treatment Guidelines: Review of the 2020 Update

▶︎
Bone Health: Osteoporosis Diagnosis & Management

▶︎
Gabapentin | TRC Healthcare Rumor vs Truth Podcast

▶︎
Spironolactone + Antiretroviral Therapy = Better HIV Outcomes? | Susana Valente

▶︎
But what is quantum computing? (Grover's Algorithm)

▶︎
My HIV Story

▶︎
CROI 2026 Updates: HIV and STI Prevention

▶︎
Acute HIV Infection

▶︎
Why We've Only Cured HIV Seven Times

▶︎
How I Found Out I was HIV+

▶︎
Perinatal HCV Epidemiology and Reporting in West Virginia by Candice Leferber, Kady Pack & Amna Umer

▶︎
Updates from the Opportunistic Infections Guidelines

▶︎
Can we cure HIV with an injection? | Dr. Hans-Peter Kiem | TEDxSeattle

▶︎
CNS Infections | Clinical Medicine

▶︎
Challenging Cases from the HIV Fellows’ Clinic

▶︎
Mini-Lecture Series: Overview of the HIV Life Cycle

▶︎
